Jan 1, 2025 · Eylea injections are a type of medication used to treat certain eye conditions such as wet age-related macular degeneration and diabetic macular edema. Common short-term side effects of Eylea injections may include eye pain, increased pressure inside the eye, and floaters in the field of vision.

Jan 1, 2025 · Eylea, known generically as aflibercept, is a groundbreaking medication that has transformed the landscape of ophthalmology. Approved by the U.S. Food and Drug Administration (FDA) in 2011, Eylea is primarily used to treat various eye diseases characterized by abnormal blood vessel growth and fluid leakage.

EYLEA is an FDA-approved, anti-VEGF, administered intravitreal injection to treat WET AMD, DME, MefRVO, and DR. Look here for more information about EYLEA. See Safety Information and full Prescribing Information.

Mar 12, 2025 · Eylea is used to treat neovascular (wet) age-related macular degeneration (nAMD) and is FDA-approved for several other eye conditions that involve the retina such as: retinopathy of prematurity (ROP). Eylea is given as an injection into the eye every 1 to 2 months by an eye specialist. Eylea gained FDA approval on November 18, 2011.

Oct 14, 2024 · Eylea (aflibercept) is a biologic drug prescribed to help prevent vision loss in certain situations. It’s a liquid solution given by healthcare professionals as an injection into the eye. Eylea...

Oct 16, 2024 · Eylea is a prescription drug used to treat certain eye conditions. Learn about the common, mild, and serious side effects it can cause and how to manage them.

Sep 11, 2024 · Eylea is the brand name for the drug, which is called aflibercept. It blocks the growth and leaking of fluid from abnormal blood vessels in the back of the eye. Those blood vessels can leak and affect vision, causing vision loss from wet AMD and diabetic eye disease.

EYLEA is an FDA-approved, anti-VEGF, administered intravitreal injection to treat WET AMD, DME, MefRVO, and DR. Look here for more information about EYLEA. See Safety Information and full Prescribing Information.

Learn the recommended dosing for EYLEA for Wet AMD, DR, DME, and MEfRVO. Review full EYLEA administration and dosing information here. See Safety Information and full Prescribing Information.

Oogprikken injecties in het oog met medicijnen voor diverse oogziekten (suikerziekte, bloedvatafsluitingen, maculadegeneratie (ooginjecties): ranibizumab (Lucentis), bevacizumab (Avastin), aflibercept (Eylea), brolucizumab (Beovu) en faricimab (Vabysmo)